Noumi has reported an 8.8% increase in full-year revenue to AUD 648.4 million in FY 2026, with adjusted operating EBITDA rising 7.6% to AUD 61.8 million. The company's statutory net loss narrowed to AUD 67.2 million from AUD 150 million a year earlier.
The results were driven by gains across Noumi's two main businesses, with plant-based milk revenue reaching a record AUD 186.3 million and dairy nutritionals revenue rising 11.6% to AUD 462 million. The company's branded portfolio now contributes more than 70% of its contribution margin.
Operating Environment
Noumi operates in a challenging environment marked by competition, commodity swings, and weaker consumer spending. Despite this, the company has continued to gain share in key categories, particularly through its Milklab brand.
Financial Outlook
Noumi has declined to provide specific financial guidance for FY 2027, citing market volatility. The company plans to maintain capital spending at roughly the same level as FY 2026 and expects to keep marketing investment for Milklab at relatively flat levels.
CEO Michael stated that 'consistent execution of our strategy is delivering results' and emphasized the strength of the company's brands. CFO Iain noted that the company expects some moderation in cream pricing after a strong year.
